Seoul, South Korea

Sang-Kyou Lee

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 1.9

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2008-2024

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovator Sang-Kyou Lee and His Contributions in Immunotherapy

Introduction: Sang-Kyou Lee is a notable inventor based in Seoul, South Korea, recognized for his significant contributions to the field of immunotherapy. With a remarkable portfolio of 11 patents, he has dedicated his research to developing innovative solutions aimed at enhancing immune responses and mitigating adverse effects in therapeutic applications.

Latest Patents: Among his latest inventions is a groundbreaking patent concerning the use of the regulatory T cell-specific surface protein LRIG-1. This invention introduces a novel approach using siRNA to inhibit the expression of the LRIG-1 surface protein, which is pivotal in the development of an immunosuppressive agent. By targeting this protein, Sang-Kyou Lee's invention promises a more effective immunosuppressive agent with reduced side effects and enhanced specificity.

Career Highlights: Throughout his career, Sang-Kyou Lee has collaborated with prominent companies in the biotechnology sector, most notably Good T Cells Incorporated and Forhumantech Co., Ltd. His work has established him as a key player in the realm of cellular immunotherapy, focusing on the intricate interplay between immune regulation and therapeutic interventions.

Collaborations: Sang-Kyou Lee has worked alongside esteemed colleagues, including Seung-Kyou Lee and Sung-Dong Park. These collaborations have further enriched his research and have contributed to advancing innovative solutions in immunotherapy.

Conclusion: Sang-Kyou Lee continues to be an influential figure in the world of inventions aimed at improving human health through innovative therapeutic strategies. His work not only highlights the importance of scientific research in the field of immunotherapy but also showcases the potential of his inventions to transform treatment methodologies. With his focus on effectively utilizing regulatory T cells, the future of immunosuppressive therapies looks promising under his guidance.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…